Jain PharmaBiotech, May 2012, Pages: 530
for the manufacture of analgesics
Future trends and needs in painmanagementPainmanagement in future healthcare systems
Systems biology approach to pain
Personalized painmanagement
Pharmacogenomics
Greystone Associates, May 2011
and acute pain is increasing and placing a higher level of emphasis on painmanagement as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly
WWMR, April 2009
are new treatments already in development that offer the promise of improved painmanagement of back pain in the near future.
Models representing patient populations and the commercial value (USD
WWMR, Feb 2009, Pages: 101
, a trend expected to continue throughout the next decade. The increasing number of cancer pain patients will be the primary driver of market value during the forecast period.
Few of the many drugs
WWMR, Sep 2008, Pages: 151
in development that offer the promise of improved painmanagement of NP in the near future. Models representing patient populations and the commercial value (USD) of this market in 2008, 2013, and 2018
Greystone Associates, Nov 2011
and participants providing the driving force behind this evolving segment of the painmanagement sector.
Evolution in PainManagement Guidelines and Treatment:
As life expectancy in the developed world increases
Datamonitor, Oct 2011, Pages: 40
, weaknesses, opportunities, and threats of their portfolios.
- In-depth discussion of brand lifecycle and portfolio management strategies of key companies in the neuropathic pain market.
- Assess trends
Frost & Sullivan, Jan 2007, Pages: 134
European Markets for PainManagement Devices This Frost & Sullivan research service titled European Markets for PainManagement Devices provides an overview of key trends in the markets. The study
Datamonitor, Dec 2009, Pages: 247
and moderate cancer pain is sub-optimal. Additionally, over a fifth of breakthrough cancer pain patients do not receive pharmacological treatment.
Oncologists initiate and manage analgesic treatment in 45
Datamonitor, Nov 2010, Pages: 297
pain
Assessment of acute pain
3. MARKET OVERVIEW
Key findings
Current treatment options for acute pain
Analgesics span multiple drug classes
Management of acute pain by severity
Datamonitor, June 2011, Pages: 46
., such as business expansion, restructuring, and contract wins
- Includes large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
This report includes Pain Therapeutics
Frost & Sullivan, July 2010, Pages: 103
by phase.
This Frost & Sullivan research service titled U.S. Opioid PainManagement Market provides an in-depth analysis of the market drivers and restraints, industry trends, and competitive environment
Frost & Sullivan, June 2010, Pages: 53
, and Anesthesiologists / PainManagers.
All respondents participated in a Web-based survey which was then analyzed through various statistical methods.
Solution/Outcome:
For the full project, all major drug delivery
Datamonitor, Jan 2011, Pages: 273
analysis of historic (2005–09) and future (2010–19) seven major market prescription sales dynamics.
- Discussion of R&D dynamics and pipeline trends in the neuropathic pain market.- Commercial and clinical
Frost & Sullivan, Dec 2007, Pages: 43
. Market forecasts are provided at the total market level for selected disease markets: Pulmonary Arterial Hypertension, Opioid and Non-Opioid PainManagement, Multiple Sclerosis, and Alzheimer’s disease. Challenges
Greystone Associates, March 2011
segments, including neurological conditions, metabolic diseases, oncology, painmanagement and reproductive health. As the incidence and prevalence of chronic illnesses increases with the aging population
Greystone Associates, Aug 2011
in Development for Transdermal Patch Delivery Systems
Antivirals
CNS
Hormones
Metabolic
PainManagement
Prescription Patch Design & Acceptance Factors
Dosing and Rate Factors
Materials Compatibility
Clinical
Frost & Sullivan, Aug 2006
. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: allergy, osteoporosis, painmanagement, vaccines, and sexual dysfunction.
Market Sectors
Expert Frost & Sullivan analysts
